ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

DFN-11 Injection in Episodic Migraine With or Without Aura

ClinicalTrials.gov ID: NCT02569853

Public ClinicalTrials.gov record NCT02569853. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 11:19 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT02569853
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Dr. Reddy's Laboratories Limited
Industry
Enrollment
268 participants

Conditions and interventions

Interventions

  • DFN-11 Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 20, 2015
Primary completion
May 29, 2017
Completion
Feb 25, 2018
Last update posted
Jul 25, 2018

2015 – 2018

United States locations

U.S. sites
16
U.S. states
14
U.S. cities
16
Facility City State ZIP Site status
Dr. Reddy's Investigational Site #18 Santa Monica California 80404
Dr. Reddy's Investigational Site #24 Jacksonville Florida 32256
Dr. Reddy's Investigational Site #23 Maitland Florida 32751
Dr. Reddy's Investigational Site #27 Boise Idaho 83716
Dr. Reddy's Investigational Site #20 Watertown Massachusetts 02472
Dr. Reddy's Investigational Site #19 Ann Arbor Michigan 48104
Dr. Reddy's Investigational Site #13 Springfield Missouri 65807
Dr. Reddy's Investigational Site #12 Albuquerque New Mexico 87102
Dr. Reddy's Investigational Site #10 Williamsville New York 14221
Dr. Reddy's Investigational Site #26 Greensboro North Carolina 27405
Dr. Reddy's Investigational Site #15 Cleveland Ohio 44122
Dr. Reddy's Investigational Site #21 Mt. Pleasant South Carolina 29464
Dr. Reddy's Investigational Site #25 Memphis Tennessee 38119
Dr. Reddy's Investigational Site #14 Dallas Texas 75231
Dr. Reddy's Investigational Site #16 Hurst Texas 76054
Dr. Reddy's Investigational Site #17 West Jordan Utah 84088

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02569853, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 25, 2018 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02569853 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →